The Role of Lymph-vascular Space Invasion towards Disease of Free Survival and Overall Survival Cancer in High-Risk Endometrial Cancer Endometrioid Type Patients

Brahmana Askandar, - and Trianggono Bagus Ariyanto, - and Indra Yuliati, - and Willy Sandhika, - (2020) The Role of Lymph-vascular Space Invasion towards Disease of Free Survival and Overall Survival Cancer in High-Risk Endometrial Cancer Endometrioid Type Patients. Systematic Review Pharmacy, 11 (5). pp. 176-180. ISSN 0976-2779

[img] Text (Artikel)
The Role of lymph-vascular space invasion towards disease of free survival and overall survival cancer in high-risk endometrial cancer endometrioid type patients.pdf

Download (298kB)
[img] Text (Peer Review)
The Role of Lymph.pdf

Download (1MB)
[img] Text (Peer Review)
The Role of lymph-vascular space invasion towards disease of free survival and overall survival cancer in high-risk endometrial cancer endometrioid type patients.pdf

Download (1MB)
[img] Text (Bukti Etik)
Bukti Etik No 2.pdf

Download (271kB)
Official URL: https://www.sysrevpharm.org/abstract/the-role-of-l...

Abstract

Major prognostic factors of endometrial cancer include stage, age, histopathological type, grading, depth of invasion of myometrium, and presence of Lymph-vascular Space Invasion (LVSI). This study evaluated the LVSI in disease free survival (DFS) and overall survival (OS) in high-risk endometrial cancer endometrioid type. This was a retrospective study. Survival analysis using Kaplan-Maier curve, log rank test, cox-regression and logistic regression were used to determine effects among variables. Among fifty-six patients, 43% of patients were <60 years, 73% with BMI <30, 17% were multiparous, and 79% were menopausal patients. There were 32% of patients with positive LVSI. Most clinical stages were found in stage III with 31 cases (55%). Patients with positive LVSI had OS lower than patients with negative LVSI (50% vs 55.3%). There were no significant results of LVSI as prognostic factor for OS. Patients with LVSI positive had survival time of 26.5 months (20.5 – 32.5). There were no significant results of LVSI as prognostic factor for DFS. Patients with positive LVSI had lower DFS than patients with negative LVSI (81.8% vs 85.7%). There were significant results of LVSI as prognostic factor for high-risk endometrioid type endometrial cancer with stage endometrial cancer with p = 0.01. LVSI acts as prognostic factor for high-risk endometrioid type endometrial cancer associated with stage endometrial cancer. However, there was no effect in DFS and OS.

Item Type: Article
Uncontrolled Keywords: Endometrial cancer, LVSI, disease free survival, overall survival
Subjects: R Medicine > R Medicine (General)
R Medicine > RG Gynecology and obstetrics
Divisions: 01. Fakultas Kedokteran > Ilmu Kebidanan dan Kandungan
Artikel Ilmiah > SCOPUS INDEXED JOURNAL
Creators:
CreatorsNIM
Brahmana Askandar, -NIDN0014057304
Trianggono Bagus Ariyanto, -UNSPECIFIED
Indra Yuliati, -NIDN8869800016
Willy Sandhika, -NIDN0014036403
Depositing User: arys fk
Date Deposited: 11 Jun 2021 03:07
Last Modified: 07 Jun 2022 04:01
URI: http://repository.unair.ac.id/id/eprint/107635
Sosial Share:

Actions (login required)

View Item View Item